Vaccination against human papillomaviruses shows great promise.
Lehtinen
Matti
M
National Public Health Institute, Department of Infectious Disease Epidemiology, 00300 Helsinki, Finland. Matti.Lehtinen@uta.fi
Paavonen
Jorma
J
D000293:Adolescent; D036022:Capsid Proteins; D005260:Female; D006801:Humans; D017589:Immunization Programs; D008297:Male; D009856:Oncogene Proteins, Viral / Q000276:immunology*; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control*; D002577:Uterine Cervical Diseases / Q000276:immunology / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D014765:Viral Vaccines
D036022:Capsid Proteins; C114580:HPV L1 protein, Human papillomavirus; D009856:Oncogene Proteins, Viral; D014765:Viral Vaccines